Cite
HARVARD Citation
Hauben, M. et al. (2021). More extreme duplication in the U.S. FDA FAERS database and a suggested check point for disproportionality analysis. Pharmacoepidemiology and drug safety. 30 (8), pp. 1140-1141. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hauben, M. et al. (2021). More extreme duplication in the U.S. FDA FAERS database and a suggested check point for disproportionality analysis. Pharmacoepidemiology and drug safety. 30 (8), pp. 1140-1141. [Online].